/ DHR
/ Market Analysis
Danaher (DHR) Stock Slides on $10B Masimo Buyout Announcement
Danaher stock fell after the company announced a $9.9B all-cash deal to buy Masimo, expanding its diagnostics and patient monitoring business.
February 17, 2026
Danaher (DHR) Tops Q4 Earnings Estimates, Issues Solid 2026 Outlook
Danaher Corporation has outperformed market expectations in Q4 2025, reporting an EPS of $2.23 and revenue of $6.84 billion, both exceeding anticipated figures.
January 28, 2026
Danaher Corporation Delivers Solid Q3 2025 Results, Exceeding Market Expectations
Danaher reported Q3 revenue of $6.1 billion and EPS of $1.89, topping estimates and maintaining a positive full-year outlook.
October 21, 2025
Danaher Corporation Reports Better-than-Expected Results for Second Quarter 2025
Danaher Corporation's second quarter results for 2025 show a notable increase in revenue and net earnings, exceeding analyst expectations.
July 22, 2025
Danaher Corporation Reports Better than Expected Q3: $818 Million Net Earnings and $5.8 Billion in Revenue
Danaher Corporation (NYSE: DHR) reported strong Q3 results with net earnings of $818 million.
October 22, 2024
Back to 
